Too many schools, not enough jobs
In 2007, a career in pharmacy appeared to offer a promising future to someone medically inclined. I expected to enter a profession that would enable me to use my education and skills to achieve a reasonable income, job security, and a fulfilling life.
Little did I know that when I graduated I would have a difficult time finding a job in my geographical area. Or that some pharmacy students would be struggling just to get the internship hours they need in order to sit for the board exam.
Only 5 years ago, all we heard was "pharmacist shortage, great jobs, great benefits, great pay." So what happened?
Where are the jobs for graduates?
I do not believe that Medicare Part D, the Affordable Care Act, and "baby boomer" healthcare demands will be sufficient to absorb the massive numbers of pharmacy graduates. And while programs such as medication therapy management are becoming increasingly important, pharmacists are not being compensated for this, nor are positions available. Meanwhile, automation and mail-order pharmacies proliferate, cutting into job opportunities.
MORE ARTICLES IN THIS ISSUE
FDA has approved azilsartan medoxomil 40-mg and 80-mg tablets for the treatment of hypertension, either alone or in combination with other antihypertensive agents. FDA has also approved roflumilast as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations (not the relief of acute bronchospasm).
ASHP has named Paul W. Abramowitz, PharmD, FASHP, as its next CEO. He will succeed Henri R. Manasee Jr., PhD, ScD, who is retiring in December.
A young pharmacist recounts his experience of volunteering in Haiti after the earthquake.
At Seattle's Group Health Cooperative, patient management is a team affair. Primary care physicians, clinical pharmacists, nurses, and assistants all work together to meet the needs of patients through a patient-centered medical home approach.
Drug Topics visits one-on-one with Mary Relling, PharmD, chair of pharmaceutical sciences at St. Jude Children's Research Hospital, who has devoted her career to finding better treatment options for childhood leukemia patients.